[1] [4] Published phase 2 trial data (Jastreboff et al., NEJM , 2023) reported dose ranges from 1 mg up to 12 mg weekly, with higher doses associated with greater weight loss but also increased rates of gastrointestinal side effects
The findings raise serious concerns about safety, labeling inconsistencies, and a near-total absence of human clinical trial data behind most of the claims being made online
However, its use is under ethical scrutiny and may violate anti-doping regulations in competitive sports.
If you are not deficient, a B12 injection does not add measurable energy or speed up weight loss
BPC-157 is commonly discussed in wellness-focused peptide therapy programs involving recovery support, mobility wellness, muscle support, and exercise recovery goals
Individuals with insulin resistance, elevated inflammation, or dysregulated adipose tissue may have blunted beta-3 receptor signaling that limits the peptides effectiveness